CAJ | 학술논문

糖尿病（ diabetes mellitus，DM）是一组以慢性血糖水平增高为特征的代谢性疾病，是由胰岛素分泌和（或）作用缺陷引起。早期发现、早期诊断、及时干预是降低 T2DM 及其并发症的关键。2010年美国糖尿病协会（ADA）将糖化血红蛋白（HbA1c）≥6.5%作为T2DM的诊断标准之一，并将其作为评价糖尿病患者长期血糖控制的“金标准”。现对HbA1 c在T2DM诊断中的应用做一综述。
당뇨병（ diabetes mellitus，DM）시일조이만성혈당수평증고위특정적대사성질병，시유이도소분비화（혹）작용결함인기。조기발현、조기진단、급시간예시강저 T2DM 급기병발증적관건。2010년미국당뇨병협회（ADA）장당화혈홍단백（HbA1c）≥6.5%작위T2DM적진단표준지일，병장기작위평개당뇨병환자장기혈당공제적“금표준”。현대HbA1 c재T2DM진단중적응용주일종술。
Diabetes mellitus( DM)was defined as a metabolic disorder of multiple aetiology characterized by chronic hy-perglycemia,resulting from disturbances of insulin secretion,and( or)defects in insulin secretion. Early detection,early diagnosis,and timely intervention are crucial to reduce the T2DM and its complications. In 2010,American Diabetes′s As-sociation(ADA)proposed new standards in which glycated hemoglobin A1c(HbA1c)≥6.5%is recommended as one of the diagnostic criteria for diabetes,and recommended it as the gold standard for evaluation of patients with diabetic long-term glycemic control. Now the application of HbA1 c in diagnosis of type 2 Diabetes Mellitus is summarized in this paper.